Pathological complete response after intraperitoneal paclitaxel and systemic combined chemotherapy in a patient with peritoneal metastases from gastric cancer: a case report
Abstract Background Despite recent progress in systemic chemotherapy, the prognosis of patients with peritoneal metastases from gastric cancer is still poor. Efficacious intraperitoneal and systemic combination chemotherapy regimens to treat patients with peritoneal metastases have recently been dev...
Main Authors: | Yoshiyuki Meguro, Hironori Yamaguchi, Joji Kitayama, Rihito Kanamaru, Shiro Matsumoto, Takashi Ui, Hidenori Haruta, Kentaro Kurashina, Shin Saito, Yoshinori Hosoya, Alan Kawarai Lefor, Naohiro Sata |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-03-01
|
Series: | Surgical Case Reports |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40792-020-00818-9 |
Similar Items
-
Intraperitoneal Paclitaxel Is Useful as Adjuvant Chemotherapy for Advanced Gastric Cancer with Serosal Exposure
by: Joji Kitayama, et al.
Published: (2014-01-01) -
Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer
by: Kazuya Takahashi, et al.
Published: (2022-09-01) -
Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery
by: Sally Mullany, et al.
Published: (2020-11-01) -
Severe hypertriglyceridemia during treatment with intraperitoneal cisplatin and paclitaxel for advanced stage fallopian tube carcinoma
by: Megan Lander, et al.
Published: (2020-05-01) -
Intraperitoneal Paclitaxel Treatment for Patients with Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination Provides a Survival Benefit
by: Tomohisa Yamamoto, et al.
Published: (2022-03-01)